Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.04 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.062 | 0.04 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |